Linomide blocks angiogenesis by breast carcinoma vascular endothelial growth factor transfectants

British Journal of Cancer

Volumn 77, Issue 7, 1998, Pages 1123-1129

  Ziche, M ^a   Donnini, S ^a   Morbidelli, L ^a   Parenti, A ^a   Gasparini, G ^b   Ledda, F ^c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b SAN BORTOLO HOSPITAL   (Italy)

^c NONE

Author keywords

Angiogenesis; Breast carcinoma; Endothelial cells; Linomide; Vascular endothelial growth factor

Indexed keywords

ANGIOGENESIS INHIBITOR; COMPLEMENTARY DNA; ROQUINIMEX; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; BREAST CARCINOMA; CANCER TRANSPLANTATION; CAPILLARY ENDOTHELIUM; CARCINOMA CELL; CELL DIVISION; CELL PROLIFERATION; CELL STRAIN MCF 7; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; DNA TRANSFECTION; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; METASTASIS; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0031929820     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.186     Document Type: Article

References (33)

1. Bengtsson M, Simonsson B, Carlsson K, Nilsson B, Smedmyr B, Termander B, Oberg G and Totterman TH (1992) Stimulation of NK cell, T cell, and monocyte functions by the novel immunomodulator Linomide after autologous bone marrow transplanation. Transplanation 53: 882-888
2. Brem SS, Gullino PM and Medina D (1977) Angiogenesis: a marker for neoplastic transformation of mammary papillary hyperplasia. Science 195: 880-881
3. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Dvorak HF and Senger DR (1993) Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 143: 1255-1262
4. Fan T-P, Jaggar R and Bicknell R (1995) Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy. Trends Pharmacol Sci 16: 57-66
5. Folkman J 1995 Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1: 27-31
6. Gasparini G and Harris AL (1995) Clinical importance of the determination of tumor angiogenesis in breast cancer: much more than a new prognostic tool. J Clin Oncol 13: 765-782
7. Gasparini G, Weidner N, Bevilacqua P, Maluta S, Dalla Palma P, Caffo O, Barbareschi M, Boracchi P, Marubini E and Pozza F (1994) Tumor microvessel density, p53 expression, tumor size and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 12: 454-466
8. Gasparini G, Barbareschi M, Boracchi P, Verderio P, Caffo O, Meli S, Dalla Palma P, Marubini E and Bevilacqua P (1995) Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy. Cancer J Sci Am 1: 131-141
9. Gasparini G, Toi M, Gion M, Verderio P, DittaDi R, Hanatani M, Matsubara I, Viante O, Bonoldi E, Boracchi P, Gatti C, Suzuki H and Tominaga T (1997) Prognostic significance of vascular endothelial growth factor protein in node negative breast carcinoma. J Natl Cancer Inst 89: 139-147
10. Harning R, Koo GC and Szalay J (1989) Regulation of the metastasis of murine ocular melanoma by natural killer cells. Invest Ophthalmol Vis Sci 30: 1909-1915
11. Horak ER, Leek R, Klenk N, Lejeune S, Smith K, Stuart N, Greenall M, Stepniewska M and Harris AL (1992) Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340: 1120-1124
12. Ichikawa T, Lamb JC, Chistensson PI, Hartley-ASP B and Isaacs JT (1992) The antitumor effects of the quinoline-3-carboxamide Linomide on dunning R-3327 rat prostatic cancers. Cancer Res 52: 3022-3028
13. Joseph IBJK, Vukanovich J and Isaacs JT (1996) Antiangiogenic treatment with Linomide as chemoprevention for prostate, seminal vesicle, and breast carcinogenesis in rodents. Cancer Res 56: 3404-3408
14. Kalland T (1986) Effects of the immunomodulator LS-2616 on growth and metastasis of the murine B16-F10 melanoma. Cancer Res 46: 3018-3022
15. Kalland T, Alm G and Stalhandske T (1985) Augmentation of mouse natural killer cell activity by LS-2616, a new immunomodulator. J Immunol 134: 3956-3961
16. Klasbrun M and Soker S (1993) VEGF/VPF: the angiogenesis factor found? Curr Biol 3: 699-702
17. Larsson E-L, Joki A and Stalhandske T (1987) Mechanism of action of the new immunomodulator LS-2616 on T cell responses. Int J Immunopharmaceut 9: 425-131
18. O'Brien T, Cranston D, Fuggle S, Bicknell R and Harris A (1995) Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res 55: 510-513
19. Parenti A, Donnini S, Morbidelli L, Granger HJ and Ziche M (1996) The effect of Linomide on the migration and the proliferation of capillary endothelial cells elicited by vascular endothelial growth factor. Br J Pharmacol 119: 619-621
20. Schelling ME, Meininger CJ, Hawker JR and Granger HJ (1988) Venular endothelial cells from bovine heart. Am J Physiol 254: H1211-H1217
21. Teicher BA, Sotomayor EA and Huang ZD (1992) Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease. Cancer Res 52: 6702-6704
22. Toi M, Kashitani J and Tominaga T (1993) Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer 55: 371-374
23. Toi M, Kondo S, Suzuki H, Yamamoto Y, Inada K, Imazawa T, Taniguchi T and Tominaga T (1996) Quantitative analyses of vascular endothelial growth factor in primary breast cancer. Cancer Res 77: 1101-1105
24. Vukanovic J and Isaacs JT (1995) Linomide inhibits angiogenesis, growth, metastasis, and macrophage infiltration within rat prostatic cancers. Cancer Res 55: 1499-1504
25. Vukanovic J, Passaniti A, Hirata T, Traystman RJ, Hartley-Asp B and Isaacs JT (1993) Antiangiogenic effects of the quinoline-3-carboxamide Linomide. Cancer Res 53: 1833-1837
26. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S and Gasparini G (1992) Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84: 1875-1887
27. Yamaoka M, Yamamoto T, Ikeyama S, Sudo K and Fujita T (1993) Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines. Cancer Res 53: 5233-5236
28. Zajchowski DA, Band V, Trask DK, Kling D, Connolly JL and Sager R (1990) Suppression of tumor-forming ability and related traits in MCF-7 human breast cancer cell by fusion with immortal mammary epithelial cells. Cell Biol 87: 2314-2318
29. Zhang H-T, Craft P, Scott PAE, Ziche M, Weilch HA, Harris AL and Bicknell R (1995) Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells. J Natl Cancer Inst 87: 213-219
30. Ziche M and Gullino PM (1982) Angiogenesis and neoplastic progression in vitro. J Natl Cancer Inst 69: 483-487
31. Ziche M, Alessandri G and Gullino PM (1989) Gangliosides promote the angiogenic response. Lab Invest 61: 629-634
32. Ziehe M, Gasparini G, Choudhuri R, Bicknell R, Morbidelli L, Parenti A and Ledda F ( 1997a) Antiangiogenic effect of Linomide on breast cancer VEGF transfectants. Oncol Rep 4: 253-256
33. Ziche M, Morbidelli L, Choudhuri R, Zhang H-T, Donnini S, Granger HJ and Bicknell R (1997b) Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast grow th factor-induced angiogenesis. J Clin Invest 99: 2625-2634